With tightening transparency requirements the pharmaceutical industry is under increasing pressure to ensure fully compliant communication and interactions through all areas of their business functions. How can you evolve current business practices to build a real cross functional, promotional compliance organisation?
Pharma Compliance Europe 2015 held on the 7th-8th October in London, will help you plan how to address the challenges and overcome the hurdles in your maturing compliance programme. It will refocus you on the core components needed to manage compliance risk in the global market and drive better practices and achieve a compliance culture.
Do you have burning questions regarding the challenges you’re facing when implementing global transparency and reporting including data quality, problems during internal test runs, transfer of value: cash vs. benefit in kind, and consent issues/confidentiality clauses to name a few?
The event’s expert speakers:
- Martin Fuerle, Head of Legal and Chief Compliance Officer, Daiichi Sankyo Europe
- Elke Baumann, Global Integrity & Compliance Director, Novartis Pharma AG
- Dr. Erik Eglite, Vice President, Chief Compliance Officer & Corporate Counsel, Lundbeck
- Dr. Christoph C. Dengler, Vice President Legal, Stada
- Stephanie Wingrove, Director, Compliance & Ethics EAME, Allergan
… will provide insight, answer your important questions and debate the future of the compliance programme and professional. If you want to be part of this year’s high level strategic and operational discussions and make a real difference to your company’s compliance best practices, attend Pharma Compliance Europe.
Don’t miss out on this chance to learn, network and discuss pressing compliance issues with leading compliance, transparency and legal professionals.
For more information please visit the WEBSITE.